2561.HK · VISEN PHARMA-B
Hong Kong · RS rating 24 · As of 2026-10-14
| Price | 18.29 HKD |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 24 / 40 / 47 / 14 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 8 / 26 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +59.2% |
| Market cap (USD) | $259.2M |